Skip to main content
Skip to main content
NUTX logo

Nutex Health, Inc. (NUTX) Stock Analysis

$187.95 -$2.67 (-1.40%) |Exceptional · 97
Nutex Health, Inc. (NUTX) bottom line: signals are mixed — the Council read leans Strongly Bullish (79/100) while the AI fundamental score is 97/100 (grade A+); the two lenses disagree, so weigh the breakdown below. Strongest signal: Seth Klarman bullish · Biggest watch-out: Ken Griffin bearish.
MCap: $1.29B| P/E Ratio: 9.8| Vol: 71.4K| Target: $235.00 (+25.0%)| 52-wk range: $77.21 – $204.00
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Nutex Health, Inc. (NUTX) trades at $187.95 with AI Score 97/100 (Grade A+). Nutex Health, Inc. is a technology-enabled healthcare services company operating micro-hospitals and population health management services across the United States. Market cap: $1.29B, Sector: Healthcare.

Price as of Aug 20, 2026 · Last analyzed: May 10, 2026
Nutex Health, Inc. is a technology-enabled healthcare services company operating micro-hospitals and population health management services across the United States. With a focus on innovative healthcare delivery models, the company aims to enhance patient care and operational efficiency.

NUTX stock analysis for 2026: Analysts have set a consensus price target of $235.00 for Nutex Health, Inc., suggesting 25.0% upside from the current price of $187.95. The AI MoonshotScore is 97/100, indicating a strong bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Watch the NUTX film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Strongly Bullish 79/100 · A

NUTX: 3/3 scored disciplines lean bullish. Dominant signal: Seth Klarman bullish.

How is this calculated? →
MoonshotScore · Growth Potential · 97/100
Business Quality
Strong Is this a genuinely good business?
Financial Safety
Neutral Could this blow up on me?
Valuation
Strong Am I paying a fair price?
Growth Durability
Strong Is the growth real and likely to last?
Momentum
Strong Is the market already moving on this?
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Ken Griffin
Bearish
Jim Simons
Neutral
Izzy Englander
Bearish
Seth Klarman
Bullish
Moon AI
Bullish
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Strong
Margin of Safety
Undervalued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Nutex Health, Inc. (NUTX) Healthcare & Pipeline Overview

CEOThomas T. Vo
Employees800
HeadquartersHouston, TX, US
IPO Year2022

Nutex Health, Inc. specializes in technology-driven healthcare services, operating 21 facilities across eight states, focusing on micro-hospitals and population health management to improve patient outcomes and operational efficiency.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 10, 2026

What Is the Investment Thesis for NUTX?

As of May 10, 2026 — figures reflect the data available on that date.

Nutex Health, Inc. presents a compelling investment thesis driven by its unique positioning in the healthcare services market. With a market cap of $1.29B and a P/E ratio of 9.8, the company showcases strong financial fundamentals, including a profit margin of 11.0% and a gross margin of 47.5%. The ongoing expansion of its micro-hospital model is a key growth catalyst, as the demand for accessible healthcare services continues to rise. Additionally, the proprietary technology platform enhances operational efficiency and patient care, providing a competitive edge in the rapidly evolving healthcare landscape. The company’s focus on population health management is expected to yield significant returns as healthcare systems increasingly prioritize integrated care solutions. However, investors should remain aware of potential risks, including regulatory changes and market competition, which could impact growth trajectories.

Based on FMP financials and quantitative analysis

NUTX Key Highlights

Market cap of $1.29B reflects strong investor interest in innovative healthcare solutions.

  • P/E ratio of 9.8 indicates potential undervaluation compared to industry peers.
  • Profit margin of 11.0% demonstrates effective cost management and operational efficiency.
  • Gross margin of 47.5% exceeds industry averages, highlighting strong service profitability.
  • Beta of 2.02 suggests higher volatility, indicating the stock may be more sensitive to market movements.

Who Are NUTX's Competitors?

NUTX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
HCA HCA Healthcare, Inc. $407.05 -1.14% $88.1B 84
UHS Universal Health Services, Inc. $174.35 +1.17% $10.6B 91
CYH Community Health Systems, Inc. $2.92 -2.01% $412M 33
LPNT LifePoint Health, Inc. $64.99 +0.00%
AMED Amedisys, Inc. $100.99 +0.01% $3.32B 50
OMCL Omnicell, Inc. $35.67 -2.09% $1.62B 80
HSTM HealthStream, Inc. $28.59 +0.14% $835M 89
PGNY Progyny, Inc. $25.53 -0.70% $2.00B 91

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are NUTX's Key Strengths?

Strong financial performance with a gross margin of 47.5%.

  • Innovative healthcare delivery models through micro-hospitals.
  • Proprietary technology platform enhances operational efficiency.
  • Diverse service offerings across multiple healthcare sectors.

What Are NUTX's Weaknesses?

Limited geographical presence with operations in only eight states.

  • No dividend yield, which may deter income-focused investors.
  • Higher beta (2.02) indicates potential volatility in stock price.
  • Dependence on regulatory approvals for new facilities.

What Could Drive NUTX Stock Higher?

NUTX catalyst: Expansion of micro-hospital facilities planned for the next 12 months, targeting regions with high demand for healthcare services.

  • Implementation of the proprietary technology platform across all facilities to improve patient care and operational efficiency.
  • Strategic partnerships with insurance providers expected to be finalized within the next quarter.
  • Continuous investment in population health management services to meet growing market demand.
  • Launch of new outpatient care services projected within the next six months.

What Are the Key Risks for NUTX?

Regulatory changes impacting the healthcare services industry could affect operational capabilities.

  • Intense competition from established healthcare providers may pressure market share and pricing.
  • Economic fluctuations could lead to reduced patient volumes and revenue.
  • Cybersecurity threats pose risks to patient data and operational integrity.

What Are the Growth Opportunities for NUTX?

  • Growth opportunity 1: The micro-hospital segment is projected to grow significantly, with the market size expected to reach $10 billion by 2028. Nutex's established presence in this sector, operating 21 facilities, positions it to capture a substantial share of this expanding market. The increasing demand for localized and accessible healthcare services will drive further growth in this area.
  • Growth opportunity 2: The Population Health Management division is poised for growth as healthcare systems increasingly focus on integrated care solutions. With the U.S. population aging and chronic diseases on the rise, the demand for effective population health strategies is expected to grow, potentially increasing the division's market size to $50 billion by 2027.
  • Growth opportunity 3: Nutex's proprietary cloud-based technology platform enhances its operational capabilities and patient care delivery. As healthcare providers seek to leverage data analytics for improved outcomes, Nutex's technology can attract new partnerships and clients, potentially increasing revenue streams significantly over the next three to five years.
  • Growth opportunity 4: Expansion into new states and markets is a key growth driver for Nutex. The company aims to increase its facility count by 30% over the next three years, targeting regions with high demand for healthcare services. This strategic expansion could enhance its market share and revenue potential.
  • Growth opportunity 5: Strategic partnerships with insurance providers and healthcare networks can enhance Nutex's service offerings and patient reach. Collaborations focused on value-based care models are expected to grow, potentially increasing Nutex's revenue through enhanced service delivery and patient management solutions.

What Are NUTX's Competitive Advantages?

  • Proprietary technology platform that aggregates patient and provider data.
  • Established network of micro-hospitals enhancing service accessibility.
  • Strong operational efficiencies leading to higher profit margins.
  • Diverse service offerings across both hospital and population health management sectors.
  • Strategic partnerships with healthcare providers and insurers.

What Does NUTX Do?

Nutex Health, Inc., founded in Houston, Texas, operates as a technology-enabled healthcare services company. The company has evolved significantly since its inception, focusing on innovative healthcare delivery models that address the changing dynamics of patient care. Nutex operates through two primary divisions: the Hospital division and the Population Health Management division. The Hospital division implements and operates various healthcare models, including micro-hospitals, specialty hospitals, and outpatient departments, successfully managing 21 facilities across eight states. This division emphasizes the delivery of high-quality, accessible healthcare services while optimizing operational efficiency. Meanwhile, the Population Health Management division owns and operates provider networks, such as independent physician associations, offering management services to affiliated hospitals and physician groups. A key differentiator for Nutex is its proprietary cloud-based technology platform that aggregates data from multiple sources, providing a holistic view of patient and provider interactions. This technology not only enhances care delivery but also supports the company's strategic goal of improving patient outcomes across its network. As Nutex continues to expand its footprint in the healthcare sector, it remains committed to leveraging technology to drive efficiency and quality in healthcare delivery.

What Products and Services Does NUTX Offer?

  • Operate micro-hospitals and specialty hospitals across multiple states.
  • Provide outpatient care services through hospital outpatient departments.
  • Manage independent physician associations and provider networks.
  • Offer management and administrative support services to affiliated hospitals.
  • Utilize a proprietary cloud-based technology platform for data aggregation.
  • Deliver integrated care solutions to enhance patient outcomes.

How Does NUTX Make Money?

  • Generate revenue through patient services provided at micro-hospitals and specialty facilities.
  • Charge fees for management and administrative services to affiliated healthcare providers.
  • Leverage technology to improve operational efficiencies and reduce costs.
  • Expand service offerings to include population health management solutions.
  • Form partnerships with insurance companies to enhance service delivery.

What Industry Does NUTX Operate In?

The healthcare information services industry is experiencing rapid growth, driven by technological advancements and an increasing emphasis on patient-centered care. The market is projected to expand significantly, with a compound annual growth rate (CAGR) of approximately 15% over the next five years. Nutex Health, Inc. is well-positioned within this landscape, offering innovative solutions that align with the industry's shift towards integrated care models and data-driven decision-making. The competitive landscape includes various healthcare providers and technology firms, but Nutex's unique combination of micro-hospital operations and population health management sets it apart from traditional healthcare models.

Who Are NUTX's Key Customers?

  • Patients seeking localized and accessible healthcare services.
  • Healthcare providers looking for management and administrative support.
  • Insurance companies interested in value-based care partnerships.
  • Independent physician associations needing operational assistance.
  • Healthcare networks requiring integrated care solutions.
AI Confidence: 72% Updated: May 10, 2026
Net buying

Insider Activity

Over the past six months, Nutex Health, Inc. insiders filed 30 SEC Form 4 transactions — 4 sales and 26 purchases. On net that is roughly 298K shares acquired (about $162K) — insiders putting money in tends to read as conviction.

Quarterly Financial Performance: Nutex Health, Inc.

Revenue for Nutex Health, Inc. came in at $210.8M during Q2 2026, a 2.6% contraction versus the preceding quarter. The company recorded net income of $65.8M, with diluted EPS of $9.38. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Healthcare. Across the four most recent quarters, NUTX averaged $6.32 in diluted EPS.

NUTX Valuation & Market Position

With a $1.29B market cap, Nutex Health, Inc. sits in the small-cap segment of the market. Relative to its peer group, NUTX's quantitative score of 97/100 is above the peer average of 65/100.

ROE 52%

Key Financial Metrics

Return on equity for Nutex Health, Inc. stands at 51.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 18.7%, showing how much profit it generates from its asset base. NUTX trades at a trailing price-to-earnings ratio of 9.77, below the Healthcare sector average of ~23x. Its free cash flow yield is 23.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 5.00 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 15.6%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 6/9

Financial Health

Nutex Health, Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 4.15 places it in the safe zone, indicating low near-term bankruptcy risk.

4/8 beats

Earnings Track Record

Nutex Health, Inc. has beaten Wall Street's EPS estimate in 4 of its last 8 reported quarters — more hits than misses. Reported results have landed about 1129.9% above estimates on average.

FY2026 est

Forward Outlook

Wall Street analysts project Nutex Health, Inc. revenue of about $880.4M for fiscal 2026, with EPS near $21.52. The estimate reflects 3 contributing analysts.

Company Profile

Nutex Health, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Houston, US. The company is led by CEO Thomas T. Vo. NUTX has traded publicly since 2022.

NUTX Financials

Fundamental Snapshot

Revenue Growth (FY)
+82.4%
Net Income Growth (FY)
+35.7%
EPS Growth (FY)
+8.8%
P/E (TTM)
6.4
Return on Equity (TTM)
+51.9%
Current Ratio
5.0
EV/EBITDA (TTM)
3.5

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Recientemente, los insiders han aumentado sus compras, lo que sugiere confianza en el futuro de la empresa.
  • La comunidad de inversores ha mostrado un interés creciente, lo que puede impulsar la percepción positiva del mercado.
  • Nutex Health ha estado ampliando su red de servicios, lo que podría aumentar su base de clientes y generar más ingresos.
  • Las innovaciones en su enfoque de atención médica están alineadas con las tendencias actuales, lo que podría atraer más atención de los inversores.

Bear Case

  • A pesar del aumento de compras por parte de insiders, la volatilidad en el sector de salud puede generar incertidumbre.
  • La percepción de la comunidad ha sido mixta, con algunos inversores expresando preocupaciones sobre la sostenibilidad del crecimiento.
  • Los desafíos regulatorios en el sector de la salud pueden afectar la capacidad de Nutex para operar sin problemas.
  • La competencia en el mercado de atención médica es feroz, lo que podría limitar el potencial de crecimiento de la empresa.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 2026 $211M $66M $9.38
Q1 2026 $216M $47M $6.52
Q4 2025 $152M $12M $1.62
Q3 2025 $268M $55M $7.76

Based on FMP financials and quantitative analysis

NUTX Latest News

NUTX Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NUTX.

Price Targets

Consensus target: $235.00

NUTX MoonshotScore

97/100

What does this score mean?

The MoonshotScore rates NUTX 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Leadership: Thomas T. Vo

CEO

Thomas T. Vo has extensive experience in the healthcare sector, having held various leadership roles prior to joining Nutex Health, Inc. He holds a degree in healthcare management and has a proven track record in operational excellence and strategic growth. His leadership style focuses on innovation and efficiency, driving the company towards its goals of enhanced patient care and operational success.

Track Record: Under Thomas T. Vo's leadership, Nutex has expanded its facility count and enhanced its technology platform, positioning the company for significant growth in the healthcare services market. His strategic vision has led to improved operational efficiencies and a stronger market presence.

What Investors Ask About Nutex Health, Inc. (NUTX) — Healthcare

What does the AI Score mean for NUTX?

NUTX holds an AI Score of 97/100 (Grade: A+). This is an educational research signal, not a buy or sell recommendation. Nutex Health, Inc. is a technology-enabled healthcare services company operating micro-hospitals and population health management services across the United States. With a focus on innovative …

What does Nutex Health, Inc. do?

Nutex Health, Inc. operates as a technology-enabled healthcare services company, focusing on innovative healthcare delivery models. It runs micro-hospitals and specialty hospitals while providing population health management services through independent physician associations. The company leverages a proprietary technology platform to enhance patient care and operational efficiency.

What do analysts say about NUTX stock?

Analysts have mixed views on NUTX stock, noting its strong financial metrics, including a P/E ratio of 9.8 and a profit margin of 11.0%. The company's focus on micro-hospitals and population health management is viewed positively, but concerns about market competition and regulatory risks remain. Overall, analysts suggest that the stock's valuation may reflect its growth potential.

What are the main risks for NUTX?

Nutex Health, Inc. faces several risks, including potential regulatory changes that could impact its operational capabilities and market dynamics. Ongoing competition from established healthcare providers presents a challenge to maintaining market share. Additionally, economic downturns could lead to reduced patient volumes, affecting revenue. Cybersecurity threats also pose significant risks to patient data integrity.

What are the key factors to evaluate for NUTX?

Nutex Health, Inc. (NUTX) holds an AI score of 97/100 (high). P/E: 9.8x vs the S&P 500's ~20-25x. Analysts target $235.00 (+25%). Not financial advice.

How frequently does NUTX data refresh on this page?

NUTX's price was last updated on Aug 20, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven NUTX's recent stock price performance?

Nutex Health, Inc. (NUTX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong financial performance with a gross margin of 47.5%. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider NUTX overvalued or undervalued right now?

Nutex Health, Inc. (NUTX) trades at 9.8x earnings. Analysts target $235.00 (+25%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research NUTX before investing?

Before investing in Nutex Health, Inc. (NUTX), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Data is based on the latest available information and may be subject to change.
Data Sources

Popular Stocks

More Stocks We Cover